AB-CE3

N/A

Report date: 2024/11/08 17:01:21
NME

Base Information

Drug NameAB-CE3
Drug Alias NameAB-CE3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein B-100 modulators
TargetsApolipoprotein B-100
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbcentra LLC
China Registration ClassN/A

Develop Information

Active CompaniesAbcentra LLC
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A